Premium
Reply to ‘Risk of malignancies associated with ustekinumab’
Author(s) -
Nardone B.,
West D.P.
Publication year - 2018
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.16007
Subject(s) - pharmacovigilance , ustekinumab , medicine , causality (physics) , european union , drug reaction , adverse effect , risk analysis (engineering) , drug , pharmacology , business , disease , infliximab , physics , quantum mechanics , economic policy